Repare Therapeutics's market cap is currently $56.11M. The company's EPS TTM is $-1.995; its P/E ratio is ―; Repare Therapeutics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.79. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 51.13M	$ 131.83M	$ 7.60M	$ 135.00K	$ 0.00
Gross Profit	$ -80.07M	$ 127.65M	$ 4.26M	$ -1.65M	$ -968.00K
Operating Income	$ -116.22M	$ -19.80M	$ -108.66M	$ -54.30M	$ -26.38M
EBITDA	$ -114.27M	$ -17.82M	$ -107.19M	$ -53.41M	$ -25.49M
Net Income	$ -93.80M	$ -29.05M	$ -106.91M	$ -53.42M	$ -27.22M
Balance Sheet
Cash & Short-Term Investments	$ 223.63M	$ 343.94M	$ 341.87M	$ 333.71M	$ 94.80M
Total Assets	$ 253.90M	$ 364.07M	$ 368.71M	$ 357.09M	$ 102.69M
Total Debt	$ 3.41M	$ 5.43M	$ 7.31M	$ 4.00M	$ 1.06M
Net Debt	$ -107.86M	$ -154.09M	$ -327.11M	$ -322.18M	$ -93.73M
Total Liabilities	$ 41.82M	$ 84.56M	$ 80.29M	$ 70.26M	$ 148.82M
Stockholders' Equity	$ 212.08M	$ 279.52M	$ 288.42M	$ 286.83M	$ -46.13M
Cash Flow
Free Cash Flow	$ -129.10M	$ -280.00K	$ -87.49M	$ -8.32M	$ -19.73M
Operating Cash Flow	$ -127.16M	$ 322.00K	$ -85.80M	$ -6.08M	$ -18.43M
Investing Cash Flow	$ 78.04M	$ -175.78M	$ -1.68M	$ -9.76M	$ -1.30M
Financing Cash Flow	$ 842.00K	$ 880.00K	$ 95.56M	$ 247.84M	$ 103.24M

Currency in USD

Repare Therapeutics Earnings and Revenue History

Income Statement >

Repare Therapeutics Debt to Assets

Balance Sheet >

Repare Therapeutics Cash Flow

Cash Flow >

Repare Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing